跳至主要内容
临床试验/IRCT201101313862N6
IRCT201101313862N6已完成2 期

Comparing improvement of lesions in leishmaniasis patients with two treatment methods including trichloroacetic Acid (TCA) and interalesional meglumine antimoniate (Glucantime) for the treatment of Lupoid leishmaniasis

Research Council of Mashhad University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 80 years(—)
性别
All

入选标准

  • presence of cutaneous leishmaniasis in less than 6 months prior to the study that their disease has been approved by direct smear and stained with Giemsa or positive dermal biopsy, 3-month treatment-free interval from the last treatment course
  • Exclusion criteria: pregnancy, breast-feeding, any administration of any other medication during the study that has anti-leishmaniasis ingredient during 2 last months, history of severe renal impairment, pulmonary and cardiovascular disease

排除标准

  • 未提供

研究者

发起方
Research Council of Mashhad University of Medical Sciences

相似试验

Comparing improvement of lesions in leishmaniasis... | 临床试验